ArticleJournal of the American Society of Nephrology : JASN2018

The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential.

Stefan Michelfelder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.